AGTR1 and polycystic ovary syndrome: With regard to women with PCOS, a case series has shown that treatment of four obese and hypertensive PCOS women with the AT1R antagonist telmisartan caused a marked reduction in the androgen levels of all four women and improved menstrual cyclicity in three of the women [113].